Postmarket Surveillance of Blood Glucose Monitor Systems Is Needed for Safety of Subjects and Accurate Determination of Effectiveness in Clinical Trials of Diabetes Drugs and Devices

Journal of diabetes science and technology - United States
doi 10.1177/1932296819843398
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications


Related search